BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196955. A total of 4 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $926,000 | -44.8% | 108 | -71.8% | 0.03% | -77.8% |
| Q2 2019 | $1,677,000 | +492.6% | 383 | +596.4% | 0.15% | +466.7% |
| Q1 2019 | $283,000 | +39.4% | 55 | 0.0% | 0.03% | -10.0% |
| Q4 2018 | $203,000 | -54.7% | 55 | -68.4% | 0.03% | -43.4% |
| Q1 2018 | $448,000 | -6.3% | 174 | -1.7% | 0.05% | -24.3% |
| Q4 2017 | $478,000 | +85.3% | 177 | +156.5% | 0.07% | +62.8% |
| Q3 2017 | $258,000 | – | 69 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $2,018,000 | 0.01% |
| SIMPLEX TRADING, LLC | 92 | $672,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |